These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3995241)

  • 1. Effects of propranolol on hepatic haemodynamics in the cirrhotic and non-cirrhotic rat.
    Jenkins SA; Baxter JN; Johnson JN; Devitt P; Shields R
    Br J Surg; 1985 May; 72(5):354-8. PubMed ID: 3995241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a selective beta 2-blocker (ICI 118,551) on hepatic haemodynamics in the cirrhotic and non-cirrhotic rat.
    Jenkins SA; Baxter JN; Johnston JN; Devitt P; Shields R
    Br J Surg; 1985 Aug; 72(8):653-6. PubMed ID: 2862948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of somatostatin on hepatic haemodynamics in the cirrhotic rat.
    Jenkins SA; Devitt P; Day DW; Baxter JN; Shields R
    Digestion; 1986; 33(3):126-34. PubMed ID: 2868955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of vasopressin on hepatic haemodynamics in the cirrhotic and non-cirrhotic rat.
    Jenkins SA; Day DW; Mooney B; Devitt P; Baxter JN; Taylor I; Shields R
    Langenbecks Arch Chir; 1985; 365(2):135-46. PubMed ID: 4046683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propranolol decreases portal pressure without changing portocollateral resistance in cirrhotic rats.
    Pizcueta MP; de Lacy AM; Kravetz D; Bosch J; Rodés J
    Hepatology; 1989 Dec; 10(6):953-7. PubMed ID: 2583690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of a somatostatin analogue SMS 201-995 on hepatic haemodynamics in the cirrhotic rat.
    Jenkins SA; Baxter JN; Corbett WA; Shields R
    Br J Surg; 1985 Nov; 72(11):864-7. PubMed ID: 2866012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of terlipressin on hemodynamics and oxygen content in conscious portal vein stenosed and cirrhotic rats receiving propranolol.
    Lebrec D; Moreau R; Cailmail S; Sogni P; Oberti F; Hadengue A
    J Hepatol; 1993 Jan; 17(1):102-7. PubMed ID: 8445208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative portal hypotensive effects as propranolol of vitamin D₃ treatment by decreasing intrahepatic resistance in cirrhotic rats.
    Lee PC; Yang YY; Lee WP; Lee KC; Hsieh YC; Lee TY; Lin HC
    J Gastroenterol Hepatol; 2015 Mar; 30(3):628-37. PubMed ID: 25187428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraportal administration of glyceryl trinitrate or nitroprusside exerts more systemic than intrahepatic effects in anaesthetised cirrhotic rats.
    Van de Casteele M; Hösli M; Sägesser H; Reichen J
    J Hepatol; 1999 Aug; 31(2):300-5. PubMed ID: 10453944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-blockade with propranolol and hepatic artery blood flow in patients with cirrhosis.
    Mastai R; Bosch J; Bruix J; Navasa M; Kravetz D; Rodés J
    Hepatology; 1989 Sep; 10(3):269-72. PubMed ID: 2759544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAF increases hepatic vascular resistance and glycogenolysis in vivo.
    Hines KL; Braillon A; Fisher RA
    Am J Physiol; 1991 Mar; 260(3 Pt 1):G471-80. PubMed ID: 1848410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of propranolol on hepatic blood flow in normal and portal hypertensive rats.
    Hillon P; Blanchet L; Lebrec D
    Clin Sci (Lond); 1982 Jul; 63(1):29-32. PubMed ID: 7083761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function.
    Albillos A; Lledó JL; Rossi I; Pérez-Páramo M; Tabuenca MJ; Bañares R; Iborra J; Garrido A; Escartín P; Bosch J
    Gastroenterology; 1995 Oct; 109(4):1257-65. PubMed ID: 7557093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
    Bosch J; Kravetz D; Rodes J
    Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of nitric oxide in systemic and hepatic haemodynamics in the rat in vivo.
    Li X; Benjamin IS; Alexander B
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Aug; 368(2):142-9. PubMed ID: 12898126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced splanchnic vasoconstriction to angiotensin II in conscious rats with biliary cirrhosis.
    Braillon A; Cailmail S; Gaudin C; Lebrec D
    J Hepatol; 1993 Jan; 17(1):86-90. PubMed ID: 8445224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrepancy between portal pressure and systemic hemodynamic changes after incremental doses of propranolol in awake portal hypertensive rats.
    Koshy A; Girod C; Lee SS; Hadengue A; Cerini R; Lebrec D
    Hepatology; 1989 Feb; 9(2):269-73. PubMed ID: 2912829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of alpha-adrenergic stimulation and beta-adrenergic blockade on azygos blood flow and splanchnic haemodynamics in patients with cirrhosis.
    Mastai R; Bosch J; Navasa M; Kravetz D; Bruix J; Viola C; Rodés J
    J Hepatol; 1987 Feb; 4(1):71-9. PubMed ID: 3033061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic effects of combined treatment with molsidomine and propranolol on portal hypertension in conscious and unrestrained cirrhotic rats.
    Hori N; Okanoue T; Sawa Y; Mori T; Kashima K
    J Gastroenterol Hepatol; 1996 Oct; 11(10):985-92. PubMed ID: 8912139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.
    Reiberger T; Payer BA; Schwabl P; Hayden H; Horvatits T; Jäger B; Hummel T; Mitterhauser M; Trauner M; Fuhrmann V; Angermayr B; Peck-Radosavljevic M;
    Liver Int; 2013 Apr; 33(4):561-8. PubMed ID: 23331709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.